<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> is one of the most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>/lethal diseases </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> is considered a risk factor for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="28230">Hesperetin</z:chebi>, a flavonone found in citrus fruits and oranges is shown to possess potent growth inhibitory effects against various human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="3" pm="."><plain>It possesses anti-inflammatory and <z:chebi fb="11" ids="22586">antioxidant</z:chebi> properties </plain></SENT>
<SENT sid="4" pm="."><plain>AIM OF THE SCOPE: In the present study, we have evaluated the chemopreventive efficacy of <z:chebi fb="0" ids="28230">hesperetin</z:chebi> against rat colon <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> in male Wistar rats </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: Group 1 served as control, received modified pellet diet and group 2 rats received 20 mg/kg body weight of <z:chebi fb="0" ids="28230">hesperetin</z:chebi> p.o. every day </plain></SENT>
<SENT sid="6" pm="."><plain>Groups 3-6 rats were given subcutaneous injections of 1,2-dimethylhydrazine (DMH, 20 mg/kg body weight) once a week for 15 consecutive weeks </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, rats in group 4 received <z:chebi fb="0" ids="28230">hesperetin</z:chebi> as in group 2 for the first 15 weeks (initiation), group 5 rats received <z:chebi fb="0" ids="28230">hesperetin</z:chebi> as in group 2 after the last injection of DMH and continued till the end of the experimental period (postinitiation) </plain></SENT>
<SENT sid="8" pm="."><plain>Group 6 rats received <z:chebi fb="0" ids="28230">hesperetin</z:chebi> as in group 2 throughout the entire experimental period of 32 weeks </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: Detection of cell proliferation markers such as proliferating cell nuclear antigen (PCNA) (immunohistochemistry), argyrophilic nucleolar organizer regions (AgNORs) (silver staining); <z:mpath ids='MPATH_3'>apoptosis</z:mpath> (immunoblotting and immunohistochemistry); angiogenic growth factors (ELISA) indicated <z:mp ids='MP_0000352'>decreased cell proliferation</z:mp> and increased apoptotic markers in the colon </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, decreased angiogenic growth factors such as vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), and downregulation of <z:chebi fb="2" ids="33699">mRNA</z:chebi> Cyclooxygenase-2 (COX-2) expressions were observed in mucosal and fecal samples of <z:chebi fb="0" ids="28230">hesperetin</z:chebi>-supplemented rats </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: <z:chebi fb="0" ids="28230">Hesperetin</z:chebi> supplementation showed an inhibition of cell proliferation markers, angiogenic growth factors, COX-2 mRNA expression and induction of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="12" pm="."><plain>Thus, <z:chebi fb="0" ids="28230">hesperetin</z:chebi> can be used as a potent chemopreventive agent against DMH-induced <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
</text></document>